Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Blood, 2005 A. Jones +24 more
semanticscholar +1 more source
Life expectancy of patients with chronic nonleukemic myeloproliferative disorders [PDF]
, 1991 C Rozmán +4 more
openalex +1 more source
Neutralize the neutrophils! Neutrophil β1 /β2 integrin activation contributes to JAK2-V617F–driven thrombosis [PDF]
, 2018 Barbui +4 more
core +2 more sources
Myeloproliferative disorders: let the partner guide!
Haematologica, 2007 Olivier Rosnet, Daniel Birnbaum
doaj +1 more source
Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.
Blood, 2014 Lamia Lamrani +8 more
semanticscholar +1 more source
Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country. [PDF]
PLoS One, 2020 Zvizdic Z +4 more
europepmc +1 more source
Diagnosis of a Myeloproliferative Disorder in Late Pregnancy
, 2013 Steven Okoli +3 more
openalex +2 more sources
New GATA1 mutation in codon 2 leads to the earliest known premature stop codon in transient myeloproliferative disorder [PDF]
, 2009 Sylvia Hoeller +5 more
openalex +1 more source
Pediatric Pulmonary Hypertension Associated With Treatment of Myeloproliferative Disorders and Malignant Tumors. [PDF]
Pulm CircChida-Nagai A +5 more
europepmc +1 more source